Autoimmune liver disease, or autoimmune hepatitis (AIH), is a chronic, progressive inflammatory liver disease of unknown etiology. The tested antibodies are considered specific serological markers of autoimmune hepatitis (AIH).
What do we test for?
Clinical significance
Autoantibodies against the Mitochondrial Fraction M2 (AMA-M2) are usually associated with Primary Biliary Liver Cirrhosis (PBC).
Autoantibodies against the Liver-Kidney Microsomes (LKM-1) are usually associated withAutoimmune Hepatitis Type-2 (AIH-2). These autoantibodies are also associated withHepatitis C.
Autoantibodies against the Soluble Liver Antigen (SLA/LP) are highly associated withAutoimmune Hepatitis Type-3 (AIH-3), and have not been described in Viral Hepatitis.
Autoantibodies against the Liver-Cytosol-Specific (LC-1) are usually associated with Chronic Active Autoimmune Hepatitis Type-2 (AIH-2).
Copyright © biolab 2024, Developed by Tech Factory